Compare CPIX & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPIX | CLST |
|---|---|---|
| Founded | 1999 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.6M | 66.9M |
| IPO Year | 2007 | 2021 |
| Metric | CPIX | CLST |
|---|---|---|
| Price | $3.94 | $15.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 41.5K | 9.3K |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 58.70 | ★ 171.79 |
| EPS | N/A | ★ 0.56 |
| Revenue | ★ $42,010,949.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $28.57 |
| Revenue Growth | ★ 16.75 | N/A |
| 52 Week Low | $1.85 | $11.10 |
| 52 Week High | $6.27 | $18.16 |
| Indicator | CPIX | CLST |
|---|---|---|
| Relative Strength Index (RSI) | 67.90 | 39.16 |
| Support Level | $3.52 | $15.90 |
| Resistance Level | $4.17 | $15.97 |
| Average True Range (ATR) | 0.33 | 0.14 |
| MACD | 0.07 | -0.05 |
| Stochastic Oscillator | 30.72 | 4.62 |
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.